OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Baxfendy works in a fundamentally different way from current therapies
Next-generation berberine formulation developed with BioSOLVE Technology targets metabolic health, blood sugar balance, and weight management
Access to genomic testing, not therapy cost, is the biggest challenge
30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage
Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone
Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare
Subscribe To Our Newsletter & Stay Updated